1) Dangguishaoyaosan and Tongxieyaofang
当归芍药散合痛泻要方
1.
The selected cases were randomly divided into two groups according to“Randomized Number Scale”: 66 patients in treatment group were administered with Dangguishaoyaosan and Tongxieyaofang; 54 patients in control group were administered with Dicetel.
第一部分临床研究 目的:通过研究进一步观察当归芍药散合痛泻要方治疗腹泻型肠易激综合征(diarrhea-irritable bowel syndrome,简称D-IBS)的临床疗效。
2) Danggui Shaoyao San
当归芍药散
1.
RP-HPLC method for the content determination of paeoniflorin in Danggui Shaoyao San;
RP-HPLC法测定当归芍药散中芍药苷的含量
2.
Effect of DSS-A-N-30,an active ingredient of Danggui Shaoyao San,on contractility of rat uterine smooth muscle in vitro;
当归芍药散活性部位DSS-A-N-30对大鼠离体子宫平滑肌收缩的影响
3.
JD-30,an active constituent extracted from Danggui Shaoyao San,ameliorates amyloid beta-protein fragment 25-35 induced inhibition of long-term potentiation of CA1 area in rat hippocampal slices;
当归芍药散活性部位JD-30对淀粉样β蛋白片段25-35抑制大鼠海马脑片CA1区长时程增强的改善作用
3) Danggui shaoyao powder
当归芍药散
1.
Pineal Mechanism of Danggui Shaoyao Powder on Anti-aging;
当归芍药散抗衰老作用的松果体机制
2.
Evaluation on Bioactivity of Inhibiting Mice Uterine Contraction in vitro and Bioactive Components of Danggui Shaoyao Powder;
当归芍药散抑制小鼠离体子宫收缩效应与效应物质分析评价
4) Dangguishaoyaosan
当归芍药散
1.
Empirical Study on Adjusting Blood Lipid、Protecting Vascular Endothelial Vell s Function of DangguiShaoyaoSan(Decoction);
当归芍药散（汤剂）调血脂、保护血管内皮细胞功能的实验研究
2.
The Effect of DangguiShaoyaoSan on Experimental Myocardial Ischemia;
当归芍药散（煎剂）对实验性心肌缺血的影响
3.
Experimental Study on Preventing & Curing Atherosclerosis with DangguiShaoyaoSan (soup);
当归芍药散防治动脉粥样硬化的实验研究
5) Optimized Danggui Shaoyao San(FBD)
当归芍药散精简方
1.
The Effect of Optimized Danggui Shaoyao San(FBD) on Cerebral Ischemia Reperfusion;
当归芍药散精简方对脑缺血再灌注损伤的改善作用
6) simplified formula of Danggui Shaoyao Powder
当归芍药散精简方(FBD)
补充资料：合要
1.核验;印证。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条